Selected Publications

Varshneya NB, Thakrar AP, Lambert E, Huhn AS.: Opioid Use Disorder Treatment in the Fentanyl Era. J Addict Med 17(1): 118-119, Feb 2023.

Thakrar AP, Uritsky TJ, Christopher C, Winston A, Ronning K, Sigueza AL, Caputo A, McFadden R, Olenik JM, Perrone J, Delgado MK, Lowenstein M, Compton P.: Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addict Sci Clin Pract 18(1): 13, Feb 24 2023.

Spadaro A, Faude S, Perrone J, Thakrar AP, Lowenstein M, Delgado MK, Kilaru AS.: Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series. J Am Coll Emerg Physicians Open. (eds.). 4(1): e12880, Jan 23 2023.

Pytell JD, Chander G, Thakrar AP, Ogunwole SM, McGinty EE.: Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J Gen Intern Med Nov 17 2022 Notes: doi: 10.1007/s11606-022-07865-y. Online ahead of print.

Thakrar AP, Kleinman RA.: Opioid withdrawal management in the fentanyl era. Addiction 117(9): 2560-2561, Sep 2022.

Varshneya NB, Thakrar AP, Hobelmann JG, Dunn KE, Huhn AS.: Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl. J Addict Med 16(4): e265-e268, Jul-Aug 2022.

Thakrar AP, Pytell J, Stoller K, Walters W, Chander G.: Why stop a good thing? A qualitative study of methadone discontinuation in the first year of treatment for opioid use disorder. Poster presentation at the College of Problems on Drug Dependence (CPDD) National Conference. Jun 2022.

Fox A, Lowenstein M, and Thakrar AP: Improving Equity in Opioid Use Disorder Treatment Acess: The Four Keys to Low-Threshold Buprenorphine Treatment. Workshop at the annual Society of General Internal Medicine (SGIM) Conference Apr 2022.

Lisa Ward: Social Media Offers a Trove of Information for Medical Researchers. Interview. Wall Street Journal Apr 2022.

Thakrar AP, Pytell J, Stoller K, Walters W, Chander G: Why stop a good thing? A qualitative study of methadone discontinuation in the first year of treatment for opioid use disorder. Poster presentation at the annual Society of General Internal Medicine (SGIM) Conference Apr 2022.